| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013432603 |
| P356 | DOI | 10.1007/BF02772244 |
| P698 | PubMed publication ID | 7544226 |
| P2093 | author name string | M G Colomb | |
| B Roussel | |||
| J Arvieux | |||
| J C Bensa | |||
| P2860 | cites work | Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I | Q72595329 |
| IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients | Q72769511 | ||
| Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
| A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection | Q28207774 | ||
| A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor | Q33350227 | ||
| Immunology and Clinical Importance of Antiphospholipid Antibodies | Q33379907 | ||
| Antiphospholipid antibodies: new perspectives on antigenic specificity | Q35166294 | ||
| Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I | Q35822631 | ||
| Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity | Q36157442 | ||
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
| Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies | Q43464737 | ||
| Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I | Q44043907 | ||
| Antiphospholipid cofactor | Q44259368 | ||
| Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome | Q44622066 | ||
| Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I | Q44728884 | ||
| Antiphospholipid antibodies differ in aPL cofactor requirement | Q45763284 | ||
| Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin | Q67866864 | ||
| Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies | Q67939879 | ||
| Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid | Q67991471 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| The beta-2-glycoprotein I and antiphospholipid antibodies | Q68018469 | ||
| Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen | Q68042865 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
| Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding | Q72081418 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 11-17 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Anti-beta 2-glycoprotein I antibodies | |
| P478 | volume | 13 |
Search more.